SC
LLY icon

Samlyn Capital’s Eli Lilly LLY Stock Holding History

Samlyn Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.5M Sell
37,125
-34,019
-48% -$34.8M 0.73% 44
2026
Q1 		$65.4M Sell
71,144
-14,436
-17% -$14.6M 1.12% 31
2025
Q4 		$92M Buy
85,580
+26,927
+46% +$25.7M 1.47% 19
2025
Q3 		$44.8M Buy
+58,653
New +$43.6M 0.62% 48
2021
Q2 		– Sell
-146,014
Closed -$27.3M – 183
2021
Q1 		$27.3M Buy
+146,014
New +$28.6M 0.38% 62

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Samlyn Capital's LLY Position: Q2 2026 in Review

Samlyn Capital reduced its Eli Lilly (LLY) stake by 48% in Q2 2026, selling an estimated $34.8M and leaving 37,125 shares worth $44.5M. The position accounts for 0.73% of the portfolio, ranked #44.

Samlyn Capital first reported a position in LLY in Q1 2021 and has held it in 5 quarters since. The position peaked at $92M in Q4 2025. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Samlyn Capital held 37,125 shares of Eli Lilly worth $44.5M as of Q2 2026.
  • Samlyn Capital sold 34,019 Eli Lilly shares in Q2 2026, an estimated $34.8M.
  • Eli Lilly made up 0.73% of Samlyn Capital's portfolio in Q2 2026, its #44 holding.
  • Samlyn Capital first reported a position in Eli Lilly in Q1 2021 and has held it in 5 quarters since.
  • Samlyn Capital's Eli Lilly position peaked at $92M in Q4 2025.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Samlyn Capital's 13F filing for Q2 2026, filed 14 Aug 2026.